Navigation Links
FDA Reviewer Questions Results of Key Avandia Trial
Date:7/11/2010

By Amanda Gardner
HealthDay Reporter

FRIDAY, July 9 (HealthDay News) -- One step ahead of a planned government review of the safety of Avandia, new doubts surfaced Friday on a key trial that helped keep the blockbuster diabetes drug on the market.

A medical reviewer for the U.S. Food and Drug Administration posted remarks on the agency's Web site Friday suggesting that drugmaker GlaxoSmithKline's "mishandling" of trial results may have masked some cardiovascular effects of Avandia (rosiglitazone).

The official's posting was part of a safety reassessment package prepared for next week's advisory panel meeting that could determine the future of the controversial drug.

At issue in the review posting were the results of the landmark RECORD (Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycemia in Diabetes) trial, which was done by Glaxo at the FDA's request. The results, announced in June of 2009, found that Avandia raised the risk of heart failure but not to a level of statistical significance. The study also concluded that the drug did not increase the risk of cardiovascular disease or overall death.

In his posting, Thomas A. Marciniak, medical team leader of the division of cardiovascular and renal products at the FDA's Center for Drug Control and Evaluation, said that "RECORD was inadequately designed and conducted to provide any reassurance about the [cardiovascular] safety of rosiglitazone" and that "RECORD suggests the (sic) rosiglitazone increases the risk for [heart attacks]."

Last June, Glaxo used the trial results to tout the drug's safety.

"RECORD provides important and reassuring information about Avandia for physicians fighting diabetes," said Dr. Ellen Strahlman, Glaxo's chief medical officer, in a statement released at the time. "We believe that the results showed that Avandia is safe."

On Friday, the company, in a prepared statement, said, "The RECORD
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Readers and Reviewers Rave about 'The Skinny On Willpower'
2. Few High-Quality Studies on Food Allergies, Say Reviewers
3. Study Questions Value of Test for Peripheral Artery Disease
4. BestFoodFacts.org -- Food, Fiber and Fuel Questions Answered
5. National Event Addresses Breakthroughs in Crohn's & Colitis Research: National Expert & Researcher Answers Key Questions on Interactive Webcast/Teleconference
6. New study questions benefits of elective removal of ovaries during hysterectomy
7. Panel questions VBAC bans, advocates expanded delivery options for women
8. New Master Cleanse Website Offers Open Q&A For Master Cleanse Diet Questions
9. New iVillage Study Reveals That Majority of Women 18-34 Go Online First With Health Questions - Before Turning to Their Doctor or Other Family Members
10. Live Online Chats Answer Questions About Vascular Disease
11. Study Questions Use of Heart Device Implants in the Very Old
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Reviewer Questions Results of Key Avandia Trial
(Date:5/25/2013)... According to an article in the June 2013 issue ... million Americans tan indoors each year and an unknown number ... health risks. New research suggests that UV rays may ... brains of some tanners (Go to goo.gl/hdwnz). , “There ... say that I fully support this contention from a scientific ...
(Date:5/25/2013)... 2013 Dr. Leslie Gerstman announced ... to lift skin on the neck, on the brow and ... Medical Aesthetics. , Ultherapy is a non-surgical procedure for the ... process to lift the skin over time. The use of ... see and then treat the deepest support layers of the ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 A disorder ... type of peripheral neuropathy. According to neuropathy expert doctor ... it is estimated that the disorder affects almost 50% ... complication arising from Diabetes. The high blood sugar levels ... and patients suffering from it usually tend to have ...
(Date:5/25/2013)... The report “Global Food Encapsulation Market (2012 ... Shell Materials, Packaging, & Geography: Trends & Forecasts” ... with analysis and forecasting of the global revenue ... and restraining factors for the global food encapsulation ... The market is segmented and revenue are forecasted ...
(Date:5/25/2013)... Absolute Surgical Specialists, serving Sun City Center ... businesses throughout the country participating in Shop Local for a ... nationwide event as he understands what military families go through ... He said, “I wanted to give something back, as I ... live here too.” , Shop Local for a Cause has ...
Breaking Medicine News(10 mins):Health News:Sun Damage – Are UV Rays Addictive? 2Health News:Dr. Leslie Gerstman Is Now Offering the Non-surgical Facelifting Procedure – Ultherapy – in NYC and NJ 2Health News:Diabetic Neuropathy treatment hits new grounds- Neuracel launches the complete natural treatment 2Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 2Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 3Health News:Dr. Craig Amshel of Absolute Surgical Specialists Offering Bowel Prep During the Shop Local for a Cause Event 2
... that would cut $6.6 million,from Medicare Advantage program ... Seniors across New,Hampshire are speaking out against proposed ... considered in the U.S. Senate. The legislation,(H.R. 6331) ... program in,New Hampshire alone and restrict seniors, health ...
... reimbursements for outpatient chemotherapy related drugs as a result ... a detrimental effect on patients requiring chemotherapy, new research ... travel distance and patient wait times for chemotherapy in ... in the July 9 issue of JAMA . ...
... to show drop-off in access predicted by critics , , ... not lost access to care despite federal legislation that ... a new report finds. , Critics feared the passing ... treatment more difficult, but investigators from the Duke Clinical ...
... recent advances in treatment, survival, study finds , , ... declines in deaths from the four most common cancers ... benefiting better educated Americans, new research from the American ... did drop significantly from 1993 to 2001, most of ...
... dietary cocktail that includes a type of omega-3 fatty ... to the latest study from MIT researchers that points ... brain diseases. , The combination of supplements, which contains ... being tested in Alzheimer,s patients. The cocktail has previously ...
... The latest developments in adipose stem cell research ... in a lab. Instead this promising revolution in ... facial fat grafting, a popular procedure developed and ... Richard Ellenbogen. Stem cell researcher and former student ...
Cached Medicine News:Health News:New Hampshire Seniors Speak Out Against Medicare Advantage Cuts 2Health News:Medicare Modernization Act not associated with major changes in access to chemotherapy 2Health News:Medicare Modernization Act not associated with major changes in access to chemotherapy 3Health News:Cancer Care Unaffected by Doctor Reimbursement Changes 2Health News:College-Educated Fare Better When Cancer Strikes 2Health News:College-Educated Fare Better When Cancer Strikes 3Health News:Study points to cocktail therapy for Alzheimer's 2Health News:Leading Plastic Surgeons Reveal Revolution in Stem Cell Research Has its Roots in Beverly Hills Plastic Surgery 2Health News:Leading Plastic Surgeons Reveal Revolution in Stem Cell Research Has its Roots in Beverly Hills Plastic Surgery 3
(Date:5/23/2013)... PARÍS, 24 de mayo de 2013  Volcano ... desarrollador y fabricante de herramientas de precisión para ... tratamiento de la enfermedad vascular periférica y coronaria, ... ( Ad enosine V asodilator I ... durante la sesión de ensayo clínico hot line ...
(Date:5/23/2013)... , May 23, 2013 Hearing health affects a ... younger, and remain socially and professionally engaged, he should address ... overriding message that the Better Hearing Institute (BHI) ... National Men,s Health Week , which leads up to ... runs from June 10 through June 16. ...
(Date:5/23/2013)... More than half of women diagnosed with ... and still have excellent outcomes. To educate women, Agendia, ... largest sources of online consumer information about breast cancer ... provide recently diagnosed women with information sources, to help ... "We anticipate these innovative social media campaigns will ...
Breaking Medicine Technology:Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 2Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 3Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 4Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3
... Inc. (OTCBB: UGNE), a leader in the ... the appointment of Thomas J. Sabatino, Jr. to its Board ... President and General Counsel for Walgreen Co., (NYSE: ... IL.  He joined Walgreens in September 2011 after having held ...
... Amsterdam Molecular Therapeutics (Euronext: AMT), a leader ... that the European Medicines Agency (EMA) has granted orphan ... of hemophilia B. Orphan designation in the European Union ... from product launch and access to the central authorization ...
Cached Medicine Technology:Unigene Strengthens Board with the Appointment of Walgreen's Executive, Thomas J. Sabatino, Jr. 2Unigene Strengthens Board with the Appointment of Walgreen's Executive, Thomas J. Sabatino, Jr. 3Unigene Strengthens Board with the Appointment of Walgreen's Executive, Thomas J. Sabatino, Jr. 4Amsterdam Molecular Therapeutics Receives Orphan Designation in the European Union for Hemophilia B Gene Therapy 2
Clearview C. Diff A is a one-step test for the direct qualitative detection of Clostridium difficile toxin A from fecal samples....
ThyroTest TSH is a rapid, qualitative test for hypothyroidism screening in adults....
... is one of the easiest tests to run ... in 15 minutes with no hands-on time. Critical ... to the child leaving the pediatrician's office and ... admission to help control the spread of RSV ...
... A & B Test simplifies rapid ... on the market just got easier ... and influenza B using one simple ... can focus on the results and ...
Medicine Products: